As filed with the Securities and Exchange Commission on February 24, 2026 Registration No. 333-293428 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AMAZE HOLDINGS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 2084 87-3905007 (I.R.S. Employer Iden ...

Core Viewpoint - Creatd, Inc. will implement a 20:1 reverse stock split of its common stock effective February 24, 2026, to meet national exchange listing requirements [1][2][7] Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of issued and outstanding shares on a 1-for-20 basis, with the stock symbol changing to $CRTDD for 20 business days starting February 24, 2026, before resuming as $CRTD [2][3] - The reverse stock split was approved by the Company's Board of Directors and Shareholders, and will be executed through FINRA's corporate action process [3][7] - The split will proportionally increase the per-share trading price while maintaining each shareholder's relative ownership interest, with no fractional shares issued [4][7] Group 2: Shareholder Impact - Shareholders holding shares in brokerage accounts or in book-entry form will not need to take any action, as the adjustment will be automatically reflected in their accounts [5]

Core Viewpoint - Noodles & Company executed a reverse stock split to avoid delisting from Nasdaq due to low share prices, with the split ratio set at 1-for-8 approved by shareholders [2][3]. Group 1: Stock Performance - The stock closed at $0.50 before the split and opened at $3.96, fluctuating between $3.57 and $4.37, ultimately closing at $3.90, and rebounding to $4.52 the following day [1]. - The reverse stock split was necessary as Noodles & Company's shares had been below the Nasdaq minimum price requirement of $1 for over six months [2]. Group 2: Shareholder Actions - Over 96% of shareholders approved the reverse stock split during a special meeting held on February 4, with the board of directors subsequently approving the 1-for-8 ratio [3]. - The company's transfer agent, Equiniti, facilitated the stock split process [3]. Group 3: Financial Performance and Strategy - Noodles & Company received a delisting determination letter from Nasdaq late last year, prompting the need for a hearing to maintain trading status [4]. - The company reported a 4% increase in same-store sales for the quarter ending September 30, 2025, but incurred a net loss of $9.2 million, equating to $0.20 per share [4]. - In September, the company engaged Piper Sandler to explore options for maximizing shareholder value, and in December, activist investor Galloway Capital Partners urged the sale of approximately 200 of its 349 company-owned restaurants [5].

Core Viewpoint - FuboTV Inc. is experiencing a significant decline in its stock price amid a broader market downturn, underperforming compared to major indices like the Nasdaq and S&P 500 [1] Group 1: Financial Performance - FuboTV reported a revenue of $1.55 billion for Q1 2026, exceeding analyst expectations of $1.10 billion, but incurred a loss of 2 cents per share [2] - The company has decided to stop providing forward guidance and announced a planned reverse stock split with a ratio between 1-for-8 and 1-for-12, which has dampened investor sentiment [2] Group 2: Technical Analysis - Over the past year, FuboTV's stock has declined by 67.75%, currently trading at $1.31, just above its 52-week low of $1.29 [3] - The stock is significantly below all key moving averages, indicating a strong bearish trend: 34% below the 20-day SMA, 46.7% below the 50-day SMA, 58.2% below the 100-day SMA, and 61.8% below the 200-day SMA [3] - The RSI is at 16.06, indicating an oversold condition, which may suggest a potential reversal or relief rally [4] Group 3: Analyst Outlook - FuboTV is expected to provide its next financial update on May 1 [5] - The stock currently carries a Buy Rating with an average price target of $3.63, despite recent declines [6] - Recent analyst actions include a downgrade by Wedbush to a target of $3.50 and upgrades by Seaport Global and Needham to targets of $3.00 [6]

Core Viewpoint - Advanced Biomed Inc. announced a reverse stock split at a ratio of 1 for 20 shares, effective February 20, 2026, to comply with Nasdaq Listing Rule 5550(a)(2) [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by a majority of the voting power on January 12, 2026, with the board finalizing the ratio on January 30, 2026 [2]. - The objective of the reverse split is to enable the company to meet the minimum bid price requirement of $1.00 per share on Nasdaq [3]. - Following the reverse split, the total issued and outstanding common shares will decrease from 27,290,710 to approximately 1,364,536 shares [6]. Group 2: Shareholder Impact - Each 20 shares will convert into one share, maintaining the par value of US$0.001, and will not alter stockholders' percentage ownership, except for minor changes due to fractional shares [4]. - No fractional shares will be issued; stockholders will receive one full share instead of any fractional share resulting from the split [5]. Group 3: Company Overview - Advanced Biomed Inc. is a biotechnology company focused on innovative biomedical products for precision medicine and advanced diagnostics [1][7]. - The company operates through a subsidiary in Taiwan and has developed a proprietary microfluidic platform for advanced circulating tumor cell detection and analysis [8].

Core Viewpoint - SMX (NASDAQ:SMX) is set to undergo a reverse stock split on February 17, 2026, consolidating every 4 shares into 1 to enhance its market position and attract more investors [1][2][3]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by SMX's shareholders on May 2, 2025, with a ratio of approximately 4.88:1, meaning shareholders will receive one new share for every 4.88 shares held [2]. - The new CUSIP number for SMX shares will be G8267K406, and the new ISIN code will be IE000B5COQZ5, which are essential for tracking and trading the adjusted shares [3]. Group 2: Current Stock Performance - SMX's stock is currently priced at $14.03, having decreased by 16.14% today, with a price drop of $2.70, and has traded between $13.01 and $16.49 during the day [4]. - Over the past year, SMX has experienced significant volatility, with a high of $1,155.43 and a low of $1.04 [4]. Group 3: Market Capitalization and Trading Volume - SMX's market capitalization is approximately $136.25 million, with a trading volume of 2,131,967 shares [5]. - The reverse stock split is expected to impact these figures by reducing the number of shares available, potentially altering market dynamics and investor perception [5].

Core Viewpoint - Cre8 Enterprise Limited is implementing a reverse stock split to increase the per share trading price of its Class A Ordinary Shares to meet Nasdaq's minimum bid price requirement of $1.00 for continued listing [5]. Group 1: Reverse Stock Split Details - The reverse stock split will occur at an exchange ratio of one share for twelve shares, reducing the number of outstanding Class A Ordinary Shares from approximately 19,667,500 to about 1,638,959 [3]. - The reverse stock split was approved by the Company's Board of Directors on January 15, 2026 [1]. - The new CUSIP number for the Class A Ordinary Shares post-split will be G2R63D113, and trading will begin on February 13, 2026, under the ticker symbol "CRE" [2]. Group 2: Shareholder Information - Registered shareholders do not need to take any action regarding the reverse stock split, as they will receive book-entry shares instead of physical stock certificates [4]. - Fractional shares resulting from the split will not be issued; instead, they will be rounded up to the next whole number [3]. Group 3: Company Overview - Cre8 Enterprise Limited provides integrated financial printing services for listed companies, IPO applicants, and private companies in Hong Kong, covering a range of services from design to logistics [6]. - The company has expanded its offerings to include complementary design services and technological support for disseminating financial reports and announcements [6].

Core Viewpoint - The company's board of directors has approved a reverse stock split at a ratio of one-for-thirty-five for both common and preferred stock, effective January 23, 2026 [1]. Group 1 - The reverse stock split will affect the company's common stock, which has a par value of $0.000001, and preferred stock, also with a par value of $0.000001 [1]. - All stock price and share count information referenced is on a pre-reverse stock split basis [1].

Core Insights - Jin Medical International Ltd. is focusing on strategic priorities and long-term growth considerations as discussed by CEO Dr. Erqi Wang during a recent CEO Fireside Chat [1][2] Group 1: Reverse Split - The company is considering a reverse stock split to regain compliance with Nasdaq's listing standards and to realign its capital structure with long-term fundamentals [3][4] Group 2: Strategic Plan for Long-Term Value Creation - The company emphasizes clear market communication, disciplined capital allocation, and a long-term perspective in its operational focus [5][6][7] Group 3: 2026–2027 Outlook - The primary objectives for 2026 and 2027 include a disciplined approach to growth, prioritizing repeatable returns and operational stability over rapid, unsustainable growth [7] Group 4: Operating Leverage - Opportunities for improving efficiency lie in broader commercialization, manufacturing scale-up, and cost normalization, with significant potential in manufacturing efficiency and product mix optimization [8][9] Group 5: Chuzhou New Factory – Strategic Importance - The Chuzhou facility is a key investment expected to enhance capacity, automation, and competitiveness, with full production capacity anticipated by the end of April 2026 [10][11] Group 6: Industry Outlook - The industry is expected to experience strong demand driven by aging populations and rising healthcare quality expectations, alongside a shift towards higher compliance and technology integration standards [13] Group 7: US–China Relations & Risk Management - The company is managing geopolitical risks through supply chain diversification and regional manufacturing flexibility to ensure resilience against external policy changes [14][15]

Core Viewpoint - Noodles & Company is implementing a reverse stock split of its Class A common stock at a ratio of 1-for-8 to avoid delisting from the Nasdaq due to low share prices [1][2]. Group 1: Stock Split Details - The reverse stock split will take effect on February 18 at 12:01 a.m. Eastern Time [1]. - Shareholders approved the split with over 96% voting in favor at a special meeting on February 4 [2]. - The stock will continue to trade under the existing symbol NLDS [2]. Group 2: Compliance and Financial Status - Noodles & Company has been out of compliance with Nasdaq's minimum share price requirement of $1 for over six months [2]. - As of market close on February 4, shares were priced at 65 cents [4]. - The company reported a 4% increase in same-store sales for the quarter ending September 30, 2025, but incurred a net loss of $9.2 million, or 20 cents per share [4]. Group 3: Strategic Moves - The company has been working on a turnaround strategy for over a year and hired Piper Sandler as an advisor to explore options for maximizing shareholder value [4]. - Activist investor Galloway Capital Partners has urged the company to sell approximately 200 of its 349 company-owned restaurants [5].